Cancer Imaging In Clear Cell Renal Carcinoma Gets ODAC Attention As Pipeline Fills
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Oncologic Drugs Advisory Committee will examine the extent (if any) to which the pre-surgical identification of clear cell carcinoma of the kidney using an imaging test provides useful clinical information. ASCO abstracts show considerable research interest in the area.